FDA-FTC Biosimilar Push Clarifies Antitrust Stance
On Feb. 3, the U.S. Food and Drug Administration and the Federal Trade Commission announced a collaboration to promote biosimilar competition. The two agencies issued a joint statement outlining goals for...To view the full article, register now.
Already a subscriber? Click here to view full article